UGCG and neoplasm: Although the exact molecular mechanisms of the Genz-dependent decrease of the tumor incidence in the CRC-model need to be further elucidated, the use of GCS inhibitors in the treatment of human colorectal cancer may represent a novel therapeutic approach.